标题
Antivirals with common targets against highly pathogenic viruses
作者
关键词
-
出版物
CELL
Volume 184, Issue 6, Pages 1604-1620
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.cell.2021.02.013
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation
- (2020) Francesca Curreli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
- (2020) Lillian B. Cohn et al. Cell Host & Microbe
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance
- (2020) Francesc Xavier RUIZ et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
- (2020) Tianshu Xiao et al. Nature Chemical Biology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
- (2020) Xiaojie Su et al. Frontiers in Microbiology
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- SnapShot: Enveloped Virus Entry
- (2020) Jason Mercer et al. CELL
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells
- (2020) Qian Wang et al. Science Translational Medicine
- Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2
- (2020) Alex Renn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
- (2020) Rodrigo Jácome et al. Scientific Reports
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Remdesivir: First Approval
- (2020) Yvette N. Lamb DRUGS
- A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
- (2020) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor
- (2020) Yoshiaki Nishimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The place for remdesivir in COVID-19 treatment
- (2020) Barnaby Young et al. LANCET INFECTIOUS DISEASES
- Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study
- (2019) Martin R Gaudinski et al. LANCET
- Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
- (2019) Marina Caskey et al. NATURE MEDICINE
- Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
- (2019) Chang-Yi Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Therapeutic strategies to target the Ebola virus life cycle
- (2019) Thomas Hoenen et al. NATURE REVIEWS MICROBIOLOGY
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
- (2019) Robert N. Kirchdoerfer et al. Nature Communications
- A Structure-Function Diversity Survey of the RNA-Dependent RNA Polymerases From the Positive-Strand RNA Viruses
- (2019) Hengxia Jia et al. Frontiers in Microbiology
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
- (2018) Sangita Venkataraman et al. Viruses-Basel
- De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
- (2018) Chao Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
- (2018) Marhiah C. Montoya et al. mBio
- Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes
- (2018) Longlong Si et al. Science Advances
- An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses
- (2017) David J. Holthausen et al. IMMUNITY
- Influenza antivirals currently in late-phase clinical trial
- (2017) Paulina Koszalka et al. Influenza and Other Respiratory Viruses
- Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
- (2017) Marie Pancera et al. Nature Chemical Biology
- Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
- (2017) Veaceslav Boldescu et al. NATURE REVIEWS DRUG DISCOVERY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Structural Biology of the Zika Virus
- (2017) Yi Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
- (2017) Yufeng Yu et al. Nature Communications
- Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
- (2016) Manu Anantpadma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Hepatitis C virus NS3/4a protease inhibitors
- (2016) John A McCauley et al. CURRENT OPINION IN PHARMACOLOGY
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor
- (2016) Jian Lei et al. SCIENCE
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
- (2016) R. Kong et al. SCIENCE
- Improving Viral Protease Inhibitors to Counter Drug Resistance
- (2016) Nese Kurt Yilmaz et al. TRENDS IN MICROBIOLOGY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Structural basis for RNA replication by the hepatitis C virus polymerase
- (2015) T. C. Appleby et al. SCIENCE
- Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
- (2015) Auda Eltahla et al. Viruses-Basel
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
- (2014) Lu Lu et al. Nature Communications
- Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance
- (2014) Stéphanie Beaucourt et al. Current Opinion in Virology
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
- (2013) Kalyan Das et al. Current Opinion in Virology
- The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
- (2013) Zhilin Ren et al. Protein & Cell
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- The structural biology of HIV-1: mechanistic and therapeutic insights
- (2012) Alan Engelman et al. NATURE REVIEWS MICROBIOLOGY
- Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
- (2011) Hideyuki Ikematsu et al. Expert Review of Anti-Infective Therapy
- Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
- (2011) Emily Happy Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, and Biological Activity of Novel 5-((Arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 Fusion Inhibitors Targeting gp41
- (2010) Shibo Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide
- (2010) W.-G. Forssmann et al. Science Translational Medicine
- An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life
- (2009) D. Xie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2008) F. George Njoroge et al. ACCOUNTS OF CHEMICAL RESEARCH
- The flavivirus polymerase as a target for drug discovery
- (2008) Hélène Malet et al. ANTIVIRAL RESEARCH
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
- (2008) Jeffrey E. Lee et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started